GoFundMe bans anti-vaccination content


GoFundMe is taking a stand against anti-vaxxers by removing any campaigns that promote misinformation about vaccines, reports The Daily Beast.
The decision comes amid heightened concern over parents who choose not to vaccinate their children, as well as an increase in measles outbreaks across the U.S.
The Daily Beast found that anti-vaxxers have been able to bring in over $170,000 over the past four years through GoFundMe. Spokesman for the company Bobby Whithorne told The Daily Beast the promotion of vaccine misinformation would "violate GoFundMe's terms of service" and therefore will be removed.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Melissa Sullivan, the executive vice president for Health Choice Connecticut which advocates for families making their own health decisions, told The Daily Beast that the decision was a "violation of the First Amendment."
GoFundMe's decision follows in the footsteps of Facebook and YouTube, both of which have recently announced plans to reduce anti-vaccine-related content on their sites.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Marianne is The Week’s Social Media Editor. She is a native Tennessean and recent graduate of Ohio University, where she studied journalism and political science. Marianne has previously written for The Daily Beast, The Crime Report, and The Moroccan Times.
-
Local elections 2025: where are they and who is on course to win?
The Explainer Reform UK predicted to make large gains, with 23 councils and six mayoralties up for grabs
By The Week UK Published
-
What is Starmer's £33m plan to smash 'vile' Channel migration gangs?
Today's Big Question PM lays out plan to tackle migration gangs like international terrorism, with cooperation across countries and enhanced police powers
By Sorcha Bradley, The Week UK Published
-
Quirky hot cross buns to try this Easter
The Week Recommends Creative, flavourful twists on the classic Easter bake, from tiramisu and stem ginger to a cheesy sharing-size treat
By Irenie Forshaw, The Week UK Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published